Q&A: What role does corneal hysteresis play in determining glaucoma risk?

Video

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Ahead of his technology article in the July 2022 issue of Optometry Times®, Thomas A. Wong, OD, FNAP, associate clinical professor of SUNY Optometry, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, both members of the SUNY Optometry class of 2022, discuss corneal hysteresis.

Related: Q&A: What is corneal hysteresis?

This transcript has been lightly edited for clarity:

What role does corneal hysteresis play in determining glaucoma risk?

Elise Regina, OD:

So the current risk factors that we all know right now..., the main five are old age, high IOP, CD ratio, high pattern standard deviation, and a thinner central corneal thickness. And also things that we consider in clinic include race, family history, the quality of the testing that we're getting and how long the patient has been followed for these things.

Related: Q&A: How is corneal hysteresis measured?

So earlier intervention is always better for these glaucoma patients, especially to prevent any permanent damage or vision loss. So when we're talking about corneal hysteresis, it just can be another one of all of these factors that we take into account when we're diagnosing and monitoring our patients for progression.

It's still unclear how exactly corneal hysteresis is related to glaucoma. But it also may be a new independent risk factor for glaucoma that we as practitioners can use when we're diagnosing and treating our patients. Since the corneal hysteresis doesn't directly affect the IOP measurements the way the central corneal thickness does, it makes the association with the IOP minimal, which is a good thing for us.

Related: Corneal hysteresis and biomechanics growing in diagnostic importance

So this literature is hypothesizing that the hysteresis may be a biomarker for the biomechanical properties of these tissues, and therefore the low corneal hysteresis readings would increase the risk for glaucomatous damage with IOP peaks and fluctuations.

Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
© 2025 MJH Life Sciences

All rights reserved.